BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27831763)

  • 1. Thyroid Patient Salivary Radioiodine Transit and Dysfunction Assessment Using Chewing Gums.
    Okkalides D
    Cancer Biother Radiopharm; 2016 Nov; 31(9):330-341. PubMed ID: 27831763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioactive iodine and the salivary glands.
    Mandel SJ; Mandel L
    Thyroid; 2003 Mar; 13(3):265-71. PubMed ID: 12729475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report].
    Macioszek A; Baczyk M; Kopeć T; Sowiński J
    Endokrynol Pol; 2008; 59(5):403-10. PubMed ID: 18979451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose.
    Lee HN; An JY; Lee KM; Kim EJ; Choi WS; Kim DY
    Clin Imaging; 2015; 39(3):396-400. PubMed ID: 25630229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
    Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
    J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
    Caglar M; Tuncel M; Alpar R
    Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of risk for symptomatic sialadenitis by post-therapeutic dual (131)I scintigraphy in patients with differentiated thyroid cancer.
    Lee SM; Lee JW; Kim SY; Han SW; Bae WK
    Ann Nucl Med; 2013 Oct; 27(8):700-9. PubMed ID: 23921836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialoendoscopic treatment for radioiodine induced sialadenitis.
    Kim JW; Han GS; Lee SH; Lee DY; Kim YM
    Laryngoscope; 2007 Jan; 117(1):133-6. PubMed ID: 17202942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer.
    Upadhyaya A; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Zhou P; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z
    Medicine (Baltimore); 2017 Jun; 96(25):e7164. PubMed ID: 28640094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of chewing-gum on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine.
    Haghighatafshar M; Nowshad R; Etemadi Z; Ghaedian T
    Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):321-325. PubMed ID: 29696945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioactive iodine: An unappreciated threat to salivary gland function.
    Sunavala-Dossabhoy G
    Oral Dis; 2018 Mar; 24(1-2):198-201. PubMed ID: 29480611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer.
    Son H; Lee SM; Yoon RG; Lee H; Lee I; Kim S; Chung WY; Lee JW
    Hell J Nucl Med; 2017; 20(1):62-70. PubMed ID: 28315910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary gland dysfunction and nasolacrimal duct obstruction: stenotic changes following I-131 therapy.
    Savage MW; Sobel RK; Hoffman HT; Carter KD; Finkelstein MW; Shriver EM
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):e50-2. PubMed ID: 24836449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.
    Raza H; Khan AU; Hameed A; Khan A
    Nucl Med Commun; 2006 Jun; 27(6):495-9. PubMed ID: 16710103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of radioactive iodine therapy on parotid gland function.
    Maier H; Bihl H
    Acta Otolaryngol; 1987; 103(3-4):318-24. PubMed ID: 3495094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.
    Nabaa B; Takahashi K; Sasaki T; Okizaki A; Aburano T
    AJNR Am J Neuroradiol; 2012 Nov; 33(10):1964-70. PubMed ID: 22555571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland toxicity after radioiodine therapy for thyroid cancer.
    Hyer S; Kong A; Pratt B; Harmer C
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):83-6. PubMed ID: 17305259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional sialendoscopy for treatment of radioiodine-induced sialadenitis.
    Bomeli SR; Schaitkin B; Carrau RL; Walvekar RR
    Laryngoscope; 2009 May; 119(5):864-7. PubMed ID: 19266587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary gland injury resulting from exposure to radioactive iodine: case reports.
    Mandel L; Liu F
    J Am Dent Assoc; 2007 Dec; 138(12):1582-7. PubMed ID: 18056102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.